Modified Harrick reaction cell for in situ/operando fiber optics diffuse reflectance UV–visible spectroscopic characterization of catalysts von Srinivasan, Priya D., Nitz, Steven R., Stephens, Kyle J., Atchison, Ed, Bravo-Suarez, Juan J.

Volltext

West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Bre... von Nitz, Ulrike, Gluz, Oleg, Clemens, Michael, Malter, Wolfram, Reimer, Toralf, Nuding, Benno, Aktas, Bahriye, Stefek, Andrea, Pollmanns, Anke, Lorenz-Salehi, Fatemeh, Uleer, Christoph, Krabisch, Petra, Kuemmel, Sherko, Liedtke, Cornelia, Shak, Steven, Wuerstlein, Rachel, Christgen, Matthias, Kates, Ronald E, Kreipe, Hans H, Harbeck, Nadia

Volltext

Prospective WSG phase III PlanB trial: Final analysis of adjuvant 4xEC→4x doc vs. 6x docetaxel/cyclophosphamide in patients with high clinical risk and intermediate-to-high genomic... von Harbeck, Nadia, Gluz, Oleg, Clemens, Michael R., Malter, Wolfram, Reimer, Toralf, Nuding, Benno, Aktas, Bahriye, Stefek, Andrea, Pollmanns, Anke, Lorenz-Salehi, Fatemeh, Uleer, Christoph, Krabisch, Petra, Kummel, Sherko, Liedtke, Cornelia, Shak, Steven, Wuerstlein, Rachel, Christgen, Matthias, Kates, Ronald, Kreipe, Hans Heinrich, Nitz, Ulrike

Volltext

Prospective comparison of recurrence score and independent central pathology assessment of prognostic tools in early breast cancer (BC): Focus on HER2, ER, PR, Ki-67 results from t... von Gluz, Oleg, Kreipe, Hans Heinrich, Christgen, Matthias, Degenhardt, Tom, Kates, Ronald E., Liedtke, Cornelia, Shak, Steven, Clemens, Michael R., Salem, Marwa, Markmann, Susanne, Liedtke, Bernd, Aktas, Bahriye, Henschen, Stephan, Pollmanns, Anke, Krabisch, Petra, Uleer, Christoph, Augustin, Doris, Thomssen, Christoph, Nitz, Ulrike, Harbeck, Nadia

Volltext